Dr. Lou ISC25 LB41 adding to research we have

Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.

Transcript (txt)

News release

Please see AHA/ASA Multimedia Materials Usage Policy.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

Download (75.4 MB)

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED